Pharmacovigilance|OMICS International|Clinical Trials

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.


Pharmacovigilance, according to Harmark and van Grootheest (2008) issued on behalf of World Health Organization (WHO), is “the science and activities relating to the detection, evaluation, understanding, and prevention of ADRs or any other drug-related problems.” This concept is very widely used and crucially involves information about ADRs. The collection of such data, originally initiated by the thalidomide tragedy in the 1960s, tries to ensure that all drugs are safe and effective in use by preventing any ADRs occurring in the future based on reporting of ADRs as they occur.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on May, 2021